No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CSL240816P380000
- 3.30
- -1.71-34.13%
15min DelayClose Jul 22 15:59 ET
3.30High3.30Low
3.30Open5.01Pre Close1 Volume2 Open Interest380.00Strike Price330.00Turnover40.81%IV11.86%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry3.30Extrinsic Value100Contract SizeAmericanOptions Type-0.1170Delta0.0043Gamma156.83Leverage Ratio-0.1732Theta-0.0320Rho-18.35Eff Leverage0.2185Vega
Intraday
- 5D
- Daily
News
Here's Why Madison Mid Cap Fund Trimmed Carlisle Companies Incorporated (CSL)
(CSL) - Analyzing Carlisle Companies's Short Interest
Express News | Carlisle Companies Inc - Stephen Aldrich Elevated to CFO for Ccm
Express News | Carlisle Companies Announces Finance Leadership Changes
Express News | Carlisle Companies Inc : Jefferies Raises Target Price to $430 From $400
Form 144 | Carlisle Companies(CSL.US) Officer Proposes to Sell 4.79 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 16, $Carlisle Companies(CSL.US)$ Officer Berlin John E intends to sell 10,995 shares of its common stock on Jul 16, with a total market value of approximately $4.79
Comments
The share price has tracked EPS growth, suggesting market sentiment towards the shares remains steady. The stock's recent performance has improved, with a better one-year total shareholder return than the five-year return. Dividends have enhanced the total shareholder return.
CSL anticipates robust annualized double-digit earnings growth over the medium term, driven by strong patient demand for its immunoglobulins franchise. The company has bounced back from the pandemic's impact on its blood plasma collections.
The positive trends in Carlisle Companies' ROCE and its ability to consistently reinvest in itself make it an attractive investment. Investors are expecting more growth in the future. However, it's important to check if these trends will continue.
The stock is seen as overpriced by valuation models, making it less attractive for purchase. With the company's low likelihood of significant earnings growth, its investment appeal is diminished. Profits could be made if share prices meet realistic values.
Read more